CBAM is a leader in the implementation of scientifically evaluated behavioral and addiction medicine services in primary care and community-based settings. Our work includes:
- Evidence-based, short term behavioral health services to patients coping with a range of chronic conditions
- Office-based medical treatment for dependence on substances of abuse including opiates, stimulants, tobacco, alcohol and marijuana
- Development of treatment manuals and technical guidelines for the care of disparate populations
- Community engagement in the adoption and implementation of high quality, evidence-based prevention and treatment for substance use and combination prevention for HIV.
CBAM was the first in Los Angeles to initiate an office-based treatment program for substance users in a primary care setting. This program utilizes FDA-approved medication to treat dependence on opioids (including prescription painkillers and heroin), as well as nicotine or alcohol in the privacy of the doctor’s office, under the supervision of UCLA physicians with expertise in treatment of addiction.
We offer outpatient treatment to adults and adolescents for a variety of substance-related issues including:
- Prescription opioid problems (prescription pain killers such as Vicodin® or Oxycontin®) including treatment with Suboxone® (buprenorphine/naloxone) and Vivitrol® (monthly naltrexone injection).
- Treatment of patients with both chronic pain and addiction with coordinated Addiction Medicine and Pain Management treatment available.
- Alcoholism including treatment with Vivitrol® (monthly naltrexone injection).
- Problems with prescription medications including sedatives and benzodiazepines (Valium®, Xanax®).
- Methamphetamine (patients also may be eligible for one of our clinical trials)
For more information on services currently available at our Santa Monica location, call us at 1-310-319-4700 or click here to request an appointment online.
This program provides evidence-based, short-term behavioral health services to existing patients of the UCLA Family Health Center. Our behavioral specialists are trained to treat a diverse range of diagnoses including, but not limited to addictions (drug and alcohol dependence and smoking cessation), mental health (depression, anxiety and panic disorders), and behavioral therapy (eating disorders).
Each year, 24.7 million people use amphetamine (MA) worldwide, which represents more consumers than individuals who use heroin or cocaine. Despite these numbers, there are currently no FDA-approved medications to treat MA dependence. And while behavioral counseling options can help many, too often it is not enough. UCLA CBAM is one of the leading methamphetamine research groups in the nation and is working to translate the latest scientific discoveries into new and more effective treatments for methamphetamine addiction. Information concerning our current methamphetamine clinical trial is below: